https://www.avient.com/sites/default/files/2020-07/case-study-one-pager-dynaflex-medical-face-mask.pdf
EUROPEAN MEDICAL
DEVICE MANUFACTURER
F A C E M A S K V E N T I L A T I O N
V A L V E
• ISO 9001 and USP VI compliant
• Compatible with overmolding onto PP
• Translucent and highly colorable
• Soft touch
• Provided valuable regulatory support and
documentation, enabling faster internal trials and
material qualification for this customer
• Worked together with customer to select the best
material from a broad portfolio of medical TPE
grades
• Trusted as a polymer supplier for multiple
healthcare applications
Dynaflex™ G2711 Thermoplastic Elastomer
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2024-11/Cesa_ Slip Additives-baby diaper -Case Study Snapshot-CNSHA3OLH90098.pdf
Baby diaper manufactureR
BABY DIAPER
MANUFACTURER
P P N O N W O V E N M U L T I L A Y E R S
• Provide slip additives with high concentrated content
• Offer products meeting customer FDA requirements
• Shorten supply lead time and reduce cost compared with
importing from EU
• Offered additives with high concentrated
content, which is unachievable for
competitors
• Provided regulatory support, significant cost
and time savings
• Compressed the timeline through on-site
color visualization, exploration, and
formulation of new colors by the expert
designer
Cesa Slip Additives
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2024-11/Cesa_ WithStand_ Antimicrobial Additives-Medical Gown-Case study snapshot.pdf
Medical gown manufacturer
MEDICAL GOWN
MANUFACTURER
P P N O N W O V E N M U L T I L A Y E R S
• Excellent anti-microbial and anti-virus performance
• Pass JIS Test
• Provide technical support including specific specs,
processing and molding recommendations
• Customized anti-virus solutions designed to
support performance standards for materials
used in the surgical environment
• Provided technical support for material
selection, part & tool design, and process
development to accelerate commercialization
• Supported customer’s products pass the JIS
test
Cesa WithStand Antimicrobial Additives
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2024-11/Cesa_ Fiber Additives-fabric mask-case study snapshot.pdf
FABRIC MASK
MANUFACTURER
P P N O N W O V E N M U L T I L A Y E R S
• Meet regulatory requirements for the application
• Provide technical support including specific color,
processing and molding recommendations
• Deliver a highly hydrophilic performance
• Developed a compliant additives solution to
meet necessary regulatory specifications
• Provided technical expertise throughout the
design and manufacturing process
• Offered an effective solution to make it soft
touch while hydrophilic
Cesa Fiber Additives
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2022-10/Omnicolor Case Study Plastic Molder.pdf
PLASTIC INJECTION
MOLDER
V A R I O U S M A R K E T S &
A P P L I C A T I O N S
• Ability to use a color concentrate in multiple resins
• Low let down ratio (LDR)
• Color consistency over time
• Offered versatile solution across resins and
in various molding methods
• Provided range of 1-3% LDRs in four
standard colors
• Achieved consistent color in a variety of
products and markets for over 10 years
Omnicolor™ Multipurpose Colorants
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2021-01/complet-craftech-non-metallic-fasteners.pdf
CRAFTECH®
N O N - M E T A L L I C F A S T E N E R S
• Corrosion resistance
• Electrical isolation
• Strength performance similar to competitive products
made of metals
• Supplied pre-colored long fiber reinforced
composites for consistent appearance
• Formulated an LFT solution to meet key
performance needs and strength to compete
against metal alternatives
• Delivered custom formulated materials on-
time with short lead times and in low release
quantities
Complēt™ Long Glass Fiber ETPU Composite
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/investor-center/news/polyone-signs-agreement-divest-performance-products-and-solutions-business-segment
Robert M.
https://www.avient.com/investor-center/news/avient-provides-third-quarter-2020-performance-update
Robert M.
https://www.avient.com/sites/default/files/2025-04/Corporate Governance Guidelines. March 2025 - Final and Approved version.pdf
Is or has been an employee of the Company within the past three years, or has an
immediate family member who is or has been an executive officer of the Company
within the past three years;
B.
The Board will promptly disclose (a) its
decision whether to accept or reject the director’s tendered resignation and (b) if
applicable, the reasons for rejecting the tendered resignation.
These committees operate in accordance with (a) their respective charters,
which are reviewed annually, (b) applicable law, and (c) applicable rules of the Securities
and Exchange Commission and the New York Stock Exchange.
https://www.avient.com/sites/default/files/2024-10/2024 AVNT Q3 Webcast Slides w appendix and non-GAAP.pdf
Microsoft PowerPoint - AVNT Q3 2024 Earnings Presentation_10.29_12PM
AVIENT CORPORATION
T H I R D Q U A R T E R 2 0 2 4 R E S U L T S A N D 2 0 2 4
F I N A N C I A L G U I D A N C E
(NYSE: AVNT)
O C T O B E R 3 1 , 2 0 2 4
DISCLAIMER
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
FX +8.5%
FX -0.4%
Total Avient +8.1%
Note: Regional Sales Percentages exclude impact of foreign exchange
COLOR, ADDITIVES & INKS SEGMENT
$487
$522
$89
$97
(in millions) (in millions)
7
+ 7%
(+8% excluding FX)
+ 9%
(+11% excluding FX)
18.3%
+40 bps *18.7%
*
* Adjusted EBITDA Margin %
• Sales growth driven by winning
new product specifications in
consumer & packaging, strong
underlying demand in healthcare
and improving demand in building
& construction
• Favorable mix and raw material
deflation contributed to EBITDA
margin expansion
SPECIALTY ENGINEERED MATERIALS SEGMENT
$268
$295
$51
$57
(in millions) (in millions)
8
• Sales growth driven by restocking
in healthcare & consumer end
markets and strong underlying
demand for composite
applications used in building &
construction, energy and defense
end markets
• Favorable mix contributed to
EBITDA margin expansion
+ 10%
(+10% excluding FX)
+ 12%
(+13% excluding FX)
19.0%
+40 bps *19.4%
*
* Adjusted EBITDA Margin %
2024 G U IDA N CE
FY 2024 GUIDANCE
Previous (Aug 6) Current
Adjusted EPS $2.55 to $2.70 $2.63 to $2.67
Adjusted EBITDA $515 to $540 million $525 to $530 million
Interest Expense $105 million $104 million
Adjusted Effective Tax Rate 23% to 25% 23% to 25%
Capital Expenditures &
Investment in S/4 Hana
~$140 million ~$140 million
10
11
• Investor Day to be held December 4, 2024 at
the NYSE, beginning at 10AM
• The focus will be to do a deep dive on the
Company’s strategy
• Registration and microsite will be available in
early November
2024 AVIENT INVESTOR DAY
AP P EN D IX
18
Performance
Additives
15%
Pigments
TiO2
Dyestuffs
Polyethylene
10%Nylon
Polypropylene
Styrenic Block
Copolymer
Other Raw
Materials
38%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
RAW MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
41%
36%
2023 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
19%
23%Industrial
Building and
7%
END MARKET REVENUE
$2,007M $358M
$1,138M $224M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$502M$3,143M
(1)
7%
20
(1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs
2023 REVENUE | $2 .0 B ILL ION
34%
37%
21%
END MARKET REGION
21
34%
21%
15%
Building &
1% Energy
COLOR, ADDITIVES & INKS
2023 REVENUE | $1 .1 B ILL ION
52%
35%
22
6%Industrial
12%
10% Defense
Building &
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
32%
26%
Building &
6%
2% Defense
1%
(18% of sales)
2023 AVIENT REGIONAL SALES
25%
Building &
(36% of sales)Transportation
22%
Building &
12%
6%
US &
Canada
(41% of sales)
59%
22%
Building &
LATAM
(5% of sales)
23
BY END MARKET
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.